MRD Monitoring Market Assessment and Strategy
Clinical Diagnostics
60
12
30
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing
Objective
A diagnostics player wanted to determine with indications / use cases to target and develop a product road map
Our Approach
Primary Research
- Conducted 30 interviews with clinicians and biopharma stakeholders to assess the opportunities for MRD in research and clinical diagnostics
- Assessed the pain-points and unmet needs associated with existing offerings, and the desired methods, performance specifications, configurations, and workflows for an ideal offering
- Specified and prioritized the indications and applications where MRD and monitoring is most impactful, and the product requirements needed for each application
Secondary Research
- Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in; reviewed clinical trial activity to identify competitive gaps where new players can compete
- Assessed epidemiology and clinical workflows to understand the relatives sizes of the different MRD / monitoring applications by cancer type
Outcome
DeciBio presented to the client a deliverable discussing discrete use cases of the highest interest to the client team, and deep dives of each. Additional content include:
- U.S. ctDNA MRD and monitoring landscape size
- Top use case prioritized by client differentiation and attractiveness
- Primary feedback highlights regarding potential utility by indication
Related Client Results
Pre-due diligence research on a potential acquisition target
Competitive Analysis
Diagnostic Advisory Board
Voice-of-Customer Research
KOL Identification
Global Companion Diagnostic Guideline Mapping and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
